Pitcairn’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $269K | Sell |
17,379
-3,293
| -16% | -$50.9K | 0.02% | 591 |
|
|
2025
Q1 | $307K | Buy |
20,672
+3,209
| +18% | +$47.7K | 0.02% | 570 |
|
|
2024
Q4 | $231K | Buy |
17,463
+5,027
| +40% | +$66.6K | 0.01% | 649 |
|
|
2024
Q3 | $177K | Sell |
12,436
-115
| -0.9% | -$1.64K | 0.01% | 687 |
|
|
2024
Q2 | $162K | Sell |
12,551
-1,650
| -12% | -$21.4K | 0.01% | 694 |
|
|
2024
Q1 | $197K | Buy |
14,201
+870
| +7% | +$12.1K | 0.01% | 690 |
|
|
2023
Q4 | $190K | Buy |
+13,331
| New | +$190K | 0.01% | 651 |
|
|
2023
Q3 | – | Sell |
-10,045
| Closed | -$158K | – | 680 |
|
|
2023
Q2 | $158K | Buy |
+10,045
| New | +$158K | 0.01% | 634 |
|